Announcement on Completion of Inclusion of the First Subject in Phase IIb Clinical Trial of CMS203 Tablets

About this update from Shandong Lukang Pharmaceutical Co., Ltd. Class A

Announcement on Completion of Inclusion of the First Subject in Phase IIb Clinical Trial of CMS203 Tablets The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shandong Lukang Pharmaceutical Co., Ltd. Class A